Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Asston Pharmaceuticals Ltd.
 
BSE Code 544445
ISIN Demat INE0SJX01015
Book Value (Rs.) 44.97
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 704.65
TTM PE (x) 18.24
TTM EPS (Rs.) 4.54
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
21-May-2026 29-May-2026 Audited Results
25-Mar-2026 30-Mar-2026 Inter alia, to consider and approve the following matters: 1. To consider the appointment of Mr. Sumit Pawar as Chief Financial Officer of the Company. 2. To consider the appointment of Mr. Yashvardhan Tupe as Additional Non-Executive Director of the Company. 3. To consider the appointment of Mr. Sandip Sharma as Additional Non-Executive Independent Director of the Company. 4. To take note of the circular resolution passed by the Company for the appointment of a statutory auditor of the Company. 5. To consider and approve the date and Notice of the Extraordinary General Meeting of the Company. 6. Other incidental Matters
29-Jan-2026 07-Feb-2026 Raising of Funds & Increase in Authorised Capital
02-Jan-2026 05-Jan-2026 Inter alia, to consider and approve the following matters: 1. To consider and approve availing the car loan facility from HDFC Bank Ltd. 2. Other agenda items, if any.
11-Nov-2025 14-Nov-2025 Half Yearly Results
13-Oct-2025 16-Oct-2025 Inter alia, to discuss the following item:- 1. To consider the appointment of CA. Yash Jain as internal auditor of the Company. 2. To consider the appointment of Mr. Yogesh Prakash Supekar as Additional Non-Executive Director of the Company. 3. To consider the Appointment of Mr. Rishi Upadhaya as Company Secretary and Compliance officer of the Company. 4. Other agenda items.
21-Aug-2025 25-Aug-2025 A.G.M.
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.